trimethylamino-1-butanol | 24004-12-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: trimethylamino-1-butanol
• 英文别名: ο-Trimethylammonio-butanol；trimethyl-(4-hydroxide-butyl)-ammonium hydroxide；Trimethyl-(4-hydroxyd-butyl)-ammoniumhydroxyd；(4-Hydroxy-butyl)-trimethyl-ammonium；4-hydroxybutyl(trimethyl)azanium
• CAS: 24004-12-4
• 化学式: C₇H₁₈NO
• 分子量: 132.226
• InChiKey: WZENRHJTCWKPAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• AMINE COMPOUND AND IONIC CONDUCTIVE AGENT, AND ELECTROCONDUCTIVE RESIN COMPOSITION
  申请人：CANON KABUSHIKI KAISHA

  公开号：US20150329474A1

  公开（公告）日：2015-11-19

  An amine compound and an ionic conductive agent excellent in electroconductivity are provided. By using the amine compound, an electroconductive resin composition suppressed in bleeding and excellent in electroconductivity is provided. The amine compound and the ionic conductive agent have a structure represented by the following general formula (1).

  提供了一种在电导率方面表现出色的胺类化合物和离子导电剂。通过使用该胺类化合物，可以提供一种抑制渗出并在电导率方面表现出色的电导性树脂组合物。该胺类化合物和离子导电剂具有以下一般式（1）所代表的结构。
• Use of Functionalized Onium Salts for Peptide Synthesis
  申请人：Vaultier Michel

  公开号：US20100292439A1

  公开（公告）日：2010-11-18

  A subject of the invention is the use of a salt with a dedicated task of formula (I): A + -L-R—OY, X − as soluble support for peptide synthesis, in which: X − represents a functional or non-functional anion, Y represents either a hydrogen atom, or a —COOR 1 group, R 1 representing in particular an alkyl group comprising 1 to 20 carbon atoms, A + represents a cationic entity, L represents an arm, in particular an alkyl group of 3 to 20 carbon atoms, R represents in particular a group of formula —C(R a )(R b )—, R a and R b representing independently of one another in particular a hydrogen or an alkyl group, comprising 1 to 20 carbon atoms.

  本发明涉及使用具有专用任务的盐的一种，其化学式为(I): A+-L-R—OY，X−作为肽合成的可溶性支持，其中：X−代表功能性或非功能性阴离子，Y代表氢原子或—COOR1基团，其中R1特指含有1至20个碳原子的烷基基团，A+代表阳离子实体，L代表一个臂，特指含有3至20个碳原子的烷基基团，R特指特定的—C(Ra)(Rb)—基团，Ra和Rb分别独立地代表氢或烷基基团，包括1至20个碳原子。
• Novel benzothiazepine and bensothiepine compounds
  申请人：Sasahara Takehiko

  公开号：US20070190041A1

  公开（公告）日：2007-08-16

  A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substitutent:

  提供了一种药物，可用作治疗和预防高脂血症的治疗剂和预防剂，以及一种药物，可用作治疗和预防与胆汁淤积有关的肝脏疾病，特别是原发性胆汁性肝硬化和原发性硬化性胆管炎的治疗剂和预防剂，以及一种药物，可用作治疗和预防肥胖症、脂肪肝和脂肪性肝炎的治疗剂和预防剂。化合物的苯并噻吩或苯并噻环代表如下式（1A），具有硫酰胺键和季铵取代基：
• Novel quaternary ammonium compounds
  申请人：Sasahara Takehiko

  公开号：US20070203115A1

  公开（公告）日：2007-08-30

  A method for inhibiting ileal bile acid transporter activity in a subject, comprising administering to said subject an effective amount of a compound represented by formula (1):

  一种抑制回肠胆汁酸转运蛋白活性的方法，包括向该受试者施用一种由式（1）所代表的化合物的有效量：
• NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS
  申请人：SASAHARA Takehiko

  公开号：US20120015925A1

  公开（公告）日：2012-01-19

  A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substituent:

  提供了一种作为治疗剂和预防剂用于高脂血症的药物，以及一种作为治疗剂和预防剂用于与胆汁淤积相关的肝疾病，特别是原发性胆汁性肝硬化和原发性硬化性胆管炎的药物，以及一种作为治疗剂和预防剂用于肥胖症、脂肪肝和脂肪性肝炎的药物。该药物是一种具有硫酰胺键和季铵基取代基的苯并噻吩或苯并噻吩化合物，其化学式为（1A）。